KCNJ11 and type 2 diabetes mellitus: First, in KCNJ11 permanent neonatal diabetes there is a fixed β-cell defect that does not change over time, whereas in type 2 diabetes there is a deterioration in β-cell function of about 5% per year of diabetes.25